Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ljq
    Junior Member
    • May 2014
    • 1

    #1

    Fusion-gene finding (in search for THE read-length)

    Hi all,

    I am very new to fusion-gene discovery and I am tasked along with some fellow colleagues to apply bioinformatic methods on clinical data for the detection of novel fusions among subtypes/groups of lymphomas patients.

    We have a few sets of 2x100bp RNA-seq (~2x75Million reads) dataset and we applied FusionCatcher onto them. After some FastQC on the input reads, we found out that the first ~15 bases of each reads may be contaminated by 'not-so-random' priming or could be even be from sequencing the adapter.

    We subsequently applied FusionCatcher to the hard-trimmed-first-20bps (lets call the candidate fusion from this set - B) and hard-trimmed-first-20bp-back-30bp datasets (result - C) and got different sets of results. Finally, we call the results on applying FusionCatcher with the original 2x100bp reads as A.

    The absolute counts of candidate fusions in the results decrease with decreasing read-lengths. C is a power-subset of B. However, there are some detected candidate which are exclusive to B as compared with A.

    After seeing this, i am wondering if there is a 'perfect' read-length to work with. (The fusions exclusive to B are under validation and i will update everyone with the results in the time to come)

    What are your experiences on dealing with RNA-seq and fusion-gene finding?

    --jq
  • lindenb
    Senior Member
    • Apr 2010
    • 143

    #2
    cross-posted: https://www.biostars.org/p/100379/

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    33 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Working...